Budget Amount *help |
¥17,420,000 (Direct Cost: ¥13,400,000、Indirect Cost: ¥4,020,000)
Fiscal Year 2023: ¥5,460,000 (Direct Cost: ¥4,200,000、Indirect Cost: ¥1,260,000)
Fiscal Year 2022: ¥5,460,000 (Direct Cost: ¥4,200,000、Indirect Cost: ¥1,260,000)
Fiscal Year 2021: ¥6,500,000 (Direct Cost: ¥5,000,000、Indirect Cost: ¥1,500,000)
|
Outline of Final Research Achievements |
This study aimed to elucidate the biological roles of WWP1, an E3 ubiquitin ligase which is involved in the development and progression of various cancers. In the genetically engineered mouse model with specific overexpression of WWP1 in the pancreatic tissue, tumorigenesis originating from acinar cells was significantly accelerated when combining with mutant KRAS expression. Furthermore, WWP1 inhibition suppressed tumor growth in pancreatic cancer cell lines, highlighting therapeutic potential of targeting WWP1.
|